06996 德琪医药－Ｂ
按盘价 
0.990 +0.020 (+2.062%) | 2023/12 - 末期 人民币() | 2022/12 人民币() | 2021/12 人民币() | 2020/12 人民币() | 2019/12 人民币() | |
| 经营活动之现金流量 | -- | (572,178,000) | (557,650,000) | (307,119,000) | (121,450,000) |
| 投资活动之现金流量 | -- | (208,156,000) | (103,884,000) | (600,567,000) | (430,367,000) |
| 融资活动之现金流量 | -- | (20,729,000) | (81,294,000) | 2,791,769,000 | 771,820,000 |
| 现金及等同现金之增加/(减少) | -- | (801,063,000) | (742,828,000) | 1,884,083,000 | 220,003,000 |
| 期初之现金及现金等价物 | -- | 1,314,178,000 | 2,094,282,000 | 290,787,000 | 49,322,000 |
| 汇率变动之影响 | -- | 92,656,000 | (37,276,000) | (80,588,000) | 21,462,000 |
| 其他 | -- | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | -- | 605,771,000 | 1,314,178,000 | 2,094,282,000 | 290,787,000 |
| 备注： | 实时报价更新时间为16/05/2024 10:56 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -581,183,000 |
| 增长率 | -3.376% |
| 每股盈利/(亏损) | RMB -0.940 |
| 每股账面资产净值 (¥) | RMB 1.700 |